PlasmaGen Biosciences, a biopharmaceutical company focused on plasma-derived therapeutics, has raised ₹150 crore in a minority equity financing round at a valuation exceeding ₹1,500 crore. The round was led by ViNS Bioproducts, with participation from HNI family offices, pharmaceutical entrepreneurs and existing investors. Company BackgroundFounded in 2010 and headquartered in Bengaluru, PlasmaGen operates in the … Continue reading PlasmaGen Biosciences Raises ₹150 Crore at ₹1,500+ Crore Valuation